Health Highlights: March 19, 2012

Here are some of the latest health and medical news developments,
compiled by the editors of HealthDay:

Women Still Have Higher Health Insurance
Rates

The same health insurance coverage still costs women more than men in
most states, even though the new federal health care law will prohibit
such “gender rating” starting in 2014.

In states that have not banned gender rating, more than 90 percent of
the best-selling health plans charge women more than men, according to a
National Women’s Law Center report to be issued this week, The New York
Times
reported.

Only 14 states have moved to limit or ban gender rating in the
individual insurance market.

Insurers say women’s premiums are higher because they’re more likely to
visit doctors, to take prescription medicines, to get regular checkups and
to have certain chronic illnesses, The Times reported.

But this explanation is “highly questionable” because disparities
between women’s and men’s rates can vary greatly in the same state,
according to Marcia D. Greenberger, a president of the National Women’s
Law Center.

“In Arkansas, for example, one health plan charges 25-year-old women 81
percent more than men, while a similar plan in the same state charges
women only 10 percent more,” she told The Times.

—–

HHS Says Health Care Law Cut Seniors’ Drug
Costs

Under the new health care law, nearly 4 million American seniors saved
about $2.16 billion through discounts for their prescription drugs in
2011, according to the Department of Health and Human Services.

Officials said making drugs more affordable for seniors should help
keep government costs down in the future, USA Today reported.

“Before, many beneficiaries were forced to stop taking the drugs,” said
Jonathon Blum, director of the Center for Medicare.

He explained that when Medicare recipients are able to afford their
medications, they are hospitalized less often for health problems such as
asthma attacks, low blood sugar and heart attacks, USA Today
reported.

—–

Use of Meds That Conflict With Cancer Drugs
Common: Study

Many patients on targeted cancer drugs also take other medicines that
may reduce the cancer treatment’s effectiveness or cause toxic side
effects, according to a new study.

Researchers found that 23 percent to 57 percent of patients who
received one of nine targeted cancer pills were also prescribed medicines
that may limit the effects of the cancer treatment, and 24 percent to 74
percent were given drugs that could cause toxic side effects when used at
the same time as the cancer drugs, Bloomberg news reported.

The study was conducted by a team at Medco Healthy Solutions Inc. and
presented today at the annual meeting of the American Society for Clinical
Pharmacology and Therapeutics.

“Oncologists are not always aware of other medications prescribed by
other doctors and vice-versa, which can pose a real hazard for their
patients on oral cancer therapies,” Steven Bowlin, one of the study
authors and senior director at Medco’s research division, said in a
statement, Bloomberg reported.

—–

Views: 0

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes